- Home
- ECOR vs THCH Comparison
ECOR vs THCH Comparison
Compare ECOR & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECOR | THCH |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 58.9M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ECOR | THCH |
|---|---|---|
| Price | $6.87 | $2.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 48.3K | 7.2K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,182,000.00 | N/A |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $32.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 57.09 | N/A |
| 52 Week Low | $4.16 | $1.69 |
| 52 Week High | $8.55 | $3.30 |
Technical Indicators
Market Signals| Indicator | ECOR | THCH |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 57.68 |
| Support Level | $4.66 | $2.04 |
| Resistance Level | $8.02 | $2.64 |
| Average True Range (ATR) | 0.68 | 0.14 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 40.72 | 59.13 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.